ARTICLE | Company News
Cytogen deal with Northwest Biotherapeutics
August 30, 2000 7:00 AM UTC
CYTO granted an exclusive worldwide sublicense to Northwest Biotherapeutics (Seattle, Wash.) to manufacture and use prostate specific membrane antigen ( PSMA) in ex vivo prostate cancer immunotherapy....